How to spot roche drug stocks?
A little-known fact is that many of the companies that have a stock market value of $1 billion or more are also companies that produce a lot of expensive medicines.
We looked at the roChe drug stocks that were at least $100 million and were the most expensive drugs for the same drugs sold in the U.S. The company that made the drug in question is Pfizer.
The stock has soared more than 300% since 2009, thanks to the company’s aggressive growth strategies in the area of cancer treatments.
Pfizer recently reported a $1.4 billion gain in the second quarter of 2017, with sales growing 10% to $1,086 billion.
The stock has also been up more than 60% since 2014.
In the roChia category, Medtronic Pharmaceuticals has the most stocks at $2.9 billion, while Novartis Pharma has a market value more than $1 million.
Roche is the second-most-expensive roChe company with $1 in stock.
Pfizers is also the top roChe brand, with a $2 billion market value.